Skip to main content
Clinical Trials/NCT03527030
NCT03527030
Terminated
Not Applicable

Cross Sectional Survey on the Use of Tobacco Products in the General Population and in Users of IQOS in London (2018-2020)

Philip Morris Products S.A.1 site in 1 country6,116 target enrollmentMarch 8, 2018
ConditionsTobacco Use

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tobacco Use
Sponsor
Philip Morris Products S.A.
Enrollment
6116
Locations
1
Primary Endpoint
Self-reported health status
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in London, United Kingdom.

The study was prematurely terminated after the first annual survey and was not be repeated due to the impossibility to recruit sufficient participants to meet the target sample size in the IQOS user sample.

Detailed Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of the Greater London area and in adult IQOS users registered in the IQOS user database of Philip Morris Limited (UK IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are: 1. Estimate the prevalence of current tobacco use status in the study population. 2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). 3. Explore the association between self-reported health status and use of tobacco products in the study population. 4. Explore the association between patterns of IQOS use including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in the Greater London area registered in UK IQOS User Database.

Registry
clinicaltrials.gov
Start Date
March 8, 2018
End Date
June 14, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not meeting the inclusion criteria

Outcomes

Primary Outcomes

Self-reported health status

Time Frame: Study duration (1 year).

Association between self-reported health status and use of tobacco products in the study population.

Perceived risk

Time Frame: Study duration (1 year).

Association between patterns of use with perceived risk.

IQOS use experience

Time Frame: Study duration (1 year).

Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of domains where IQOS may have potential benefits).

Prevalence of current tobacco use

Time Frame: Study duration (1 year).

Prevalence of current tobacco use status in the study population.

Past tobacco use status

Time Frame: Study duration (1 year).

Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.

Study Sites (1)

Loading locations...

Similar Trials